Clinical Trial Update: To Compare Relative Bioavailability of Two Clinical Formulations of Linifanib. [Phase 1]

View source ↗

Summary

Phase 1 study comparing the relative bioavailability of two linifanib formulations in patients with solid tumors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• Linifanib (linifanib)

Snippet

Sponsor: Abbott | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED